(1 - 6 von 17
)
Bertrand Damour | Les Echos
www.lesechos.fr
· Bertrand Damour rejoint Rabobank International à Londres en qualité de directeur des activités de risk advisory. Il sera chargé à l'échelle ...
An almost complete C-suite for Swiss startups
www.startupticker.ch
· For its next phase, the company has welcomed Bertrand Damour as Chief Executive Officer. Damour has 20 years' management experience in ...
Merck acquires OncoEthix
www.biospectrumasia.com
The acquisition expands Merck's oncology portfolio with novel oral BET inhibitor, OTX015
Merck acquires Swiss firm OncoEthix | Pharmafile
www.pharmafile.com
Pharmafile.com is a leading portal for the … industry, providing industry professionals with pharma news, jobs, events, and service company...
OncoEthix In-Licenses OTX015 | Technology Networkswww.technologynetworks.com › news › oncoethix-i...
www.technologynetworks.com
· Dr Kay Noel, Chief Operating Officer who led the licensing effort with Bertrand Damour, Chief Executive Officer, said: “We are excited about the ...
Oncoethix startet Phase-Ib-Studien zu OTX015 im Rahmen der Behandlung...
www.onvista.de
· Bertrand Damour, CEO von Oncoethix, ergänzte: „Wir sind überzeugt, dass OTX015 über das Potenzial verfügt, sich zu einem bedeutenden ...
sortiert nach Relevanz / Datum